These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38952388)

  • 1. Case report: Exceptional transmission of congenital hyperinsulinism from a focal CHI mother to her diffuse CHI dichorionic diamniotic twins.
    Telehuz D; Plesa O; Bouilloud F; Wucher H; De Lonlay P; Bérat CM; Saint-Martin C; Dupuy O; Arnoux JB
    Front Endocrinol (Lausanne); 2024; 15():1408003. PubMed ID: 38952388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic characteristics of patients with congenital hyperinsulinism in 21 non-consanguineous families from Serbia.
    Raicevic M; Milenkovic T; Hussain K; Djordjevic M; Martic J; Todorovic S; Mitrovic K; Sarajlija A; Vukovic R
    Eur J Pediatr; 2021 Sep; 180(9):2815-2821. PubMed ID: 33770274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy.
    Taylor-Miller T; Houghton J; Munyard P; Kumar Y; Puvirajasinghe C; Giri D
    J Pediatr Endocrinol Metab; 2020 May; 33(5):671-674. PubMed ID: 32267248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of a Long-Acting Somatostatin Analogue (Lanreotide) in Three Children with Focal Forms of Congenital Hyperinsulinaemic Hypoglycaemia.
    Dastamani A; Güemes M; Pitfield C; Morgan K; Rajab M; Rottenburger C; Bomanji J; De Coppi P; Dattani M; Shah P
    Horm Res Paediatr; 2019; 91(1):56-61. PubMed ID: 30114684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
    Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C
    Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentation and treatment response to diazoxide in two siblings with congenital hyperinsulinism as a result of a novel compound heterozygous ABCC8 missense mutation.
    Galcheva S; Iotova V; Ellard S; Flanagan SE; Halvadzhiyan I; Petrova C; Hussain K
    J Pediatr Endocrinol Metab; 2017 Apr; 30(4):471-474. PubMed ID: 28328534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus therapy in a patient with severe hyperinsulinaemic hypoglycaemia due to a compound heterozygous ABCC8 gene mutation.
    Shah P; Arya VB; Flanagan SE; Morgan K; Ellard S; Senniappan S; Hussain K
    J Pediatr Endocrinol Metab; 2015 May; 28(5-6):695-9. PubMed ID: 25518065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histological heterogeneity of congenital hyperinsulinism due to paternally inherited heterozygous ABCC8/KCNJ11 mutations.
    Arya VB; Guemes M; Nessa A; Alam S; Shah P; Gilbert C; Senniappan S; Flanagan SE; Ellard S; Hussain K
    Eur J Endocrinol; 2014 Dec; 171(6):685-95. PubMed ID: 25201519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifedipine in Congenital Hyperinsulinism - A Case Report.
    Khawash P; Hussain K; Flanagan SE; Chatterjee S; Basak D
    J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):151-4. PubMed ID: 26316440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare case of congenital hyperinsulinism (CHI) due to dual genetic aetiology involving HNF4A and ABCC8.
    Apperley L; Giri D; Houghton JAL; Flanagan SE; Didi M; Senniappan S
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):301-304. PubMed ID: 30730840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial ABCC8 gene deletion mutations causing diazoxide-unresponsive hyperinsulinaemic hypoglycaemia.
    Flanagan S; Damhuis A; Banerjee I; Rokicki D; Jefferies C; Kapoor R; Hussain K; Ellard S
    Pediatr Diabetes; 2012 May; 13(3):285-9. PubMed ID: 21978130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and phenotype-genotype analysis in Turkish patients with congenital hyperinsulinism; predominance of recessive KATP channel mutations.
    Demirbilek H; Arya VB; Ozbek MN; Akinci A; Dogan M; Demirel F; Houghton J; Kaba S; Guzel F; Baran RT; Unal S; Tekkes S; Flanagan SE; Ellard S; Hussain K
    Eur J Endocrinol; 2014 Jun; 170(6):885-92. PubMed ID: 24686051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A compound heterozygous mutation of ABCC8 gene causing a diazoxide-unresponsive congenital hyperinsulinism with an atypical form: Not a focal lesion in the pancreas reported by ¹⁸F-DOPA-PET/CT scan.
    Zhang W; Liu L; Wen Z; Cheng J; Li C; Li X; Niu H; Wang F; Sheng H; Liu H
    Gene; 2015 Nov; 572(2):222-6. PubMed ID: 26162674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutation.
    Kiff S; Babb C; Guemes M; Dastamani A; Gilbert C; Flanagan SE; Ellard S; Barton J; Dattani M; Shah P
    Endocrinol Diabetes Metab Case Rep; 2019 Feb; 2019():. PubMed ID: 30753133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutation c.597_598dup in exon 5 of ABCC8 gene causing congenital hyperinsulinism.
    Jindal R; Ahmad A; Siddiqui MA; Kochar IS; Wangnoo SK
    Diabetes Metab Syndr; 2014; 8(1):45-7. PubMed ID: 24661758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus in infants with congenital hyperinsulinism (CHI) - a single-centre experience.
    Panigrahy N; Chirla DK; Bagga N; Gunda RK; Sukhija B; Reddy L
    Eur J Pediatr; 2022 Jan; 181(1):407-412. PubMed ID: 34304300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paternally inherited ABCC8 mutation causing diffuse congenital hyperinsulinism.
    Chandran S; Peng FY; Rajadurai VS; Lu YT; Chang KT; Flanagan SE; Ellard S; Hussain K
    Endocrinol Diabetes Metab Case Rep; 2013; 2013():130041. PubMed ID: 24616771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus precipitating diabetes mellitus in a patient with congenital hyperinsulinaemic hypoglycaemia due to autosomal dominant ABCC8 mutation.
    Dastamani A; Güemes M; Walker J; Shah P; Hussain K
    J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1219-1222. PubMed ID: 28985184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening.
    Maiorana A; Barbetti F; Boiani A; Rufini V; Pizzoferro M; Francalanci P; Faletra F; Nichols CG; Grimaldi C; de Ville de Goyet J; Rahier J; Henquin JC; Dionisi-Vici C
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):679-88. PubMed ID: 24383515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus in the treatment of three infants with diffuse congenital hyperinsulinism.
    Al-Balwi R; Al-Atawi M; Al-Otaibi A; Babiker O; Al-Mutair A
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):1013-1017. PubMed ID: 28787272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.